Ristova 100mg/10ml (Rituximab Vials) 100mg/10ml

Ristova 100mg/10ml is a prescription medication containing rituximab, a monoclonal antibody used in certain treatments. This sterile injectable solution comes in vials for clinical administration. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance.

Strength

100mg/10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Roche Product India pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ristova 100mg/10ml is used to treat autoimmune conditions and certain cancers by targeting specific immune cells. It helps reduce symptoms in rheumatoid arthritis, vasculitis, and non-Hodgkin lymphoma when prescribed. Patients often ask, 'what is Ristova 100mg/10ml used for' in managing chronic inflammatory diseases. The medication works by modifying immune responses.

Side Effects

Common effects of Ristova 100mg/10ml include temporary flu-like symptoms after administration, such as fever or chills. Some patients may experience fatigue or mild pain at the injection site. These effects are typically short-lived and monitored by healthcare professionals during treatment.

Precautions & Warnings

Ristova 100mg/10ml should only be handled and administered by trained medical staff in a clinical setting. Patients must disclose all medications and medical history before use. Regular monitoring is required to manage potential reactions. Keep vials refrigerated and protected from light.

Avoid Interactions

Ristova 100mg/10ml may interact with immunosuppressants, vaccines, or other biologics. Alcohol and certain antibiotics could affect its efficacy or safety. Always inform your doctor about all substances being taken. CYP450 enzyme inhibitors may alter rituximab metabolism.

Frequently Asked Questions

Ristova 100mg/10ml is used to treat autoimmune diseases like rheumatoid arthritis and certain cancers such as non-Hodgkin lymphoma.

It is administered as an intravenous infusion by healthcare professionals in a clinical setting.

Ristova 100mg/10ml requires a prescription and is typically dispensed through licensed pharmacies or hospitals.

Common side effects include flu-like symptoms, fatigue, and mild injection site reactions.

Store Ristova 100mg/10ml between 2-8°C and protect from light until use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.